̽»¨¾«Ñ¡

Tatja Hirvikoski’s current clinical affiliation is at Habilitation &
Health, Stockholm, where she has a position as Head of the Unit for Research,
Development and Education. Her research affiliation is at Center for
Neurodevelopmental Disorders at ̽»¨¾«Ñ¡, KIND.
During 2016 Tatja Hirvikoski and her co-authors received two international
prizes for their publication "Premature mortality in autism spectrum disorder
[1]":
* Autism Speaks Top 10 Research Papers [2]
* Spectrum News Top 10 Notable Research Papers [3]
Tatja Hirvikoski is Associate Professor (2016) and neuropsychologist
(specialist degree 2009).
[1]
[2] %20
[3]

Tatja Hirvikoski has long-term research and clinical experience of assessment
and treatment of neurodevelopmental disorders in adults. She has been working
with development and dissemination of stepped care model for adults with
ADHD. A core idea of the model is to combine pharmacological and
non-pharmacological treatment methods to meet each individual’s needs and
to optimize effective and feasible care pathways. Tatja Hirvikoski and her
group has developed the PEGASUS psychoeducational groups for adults with ADHD
and their significant others, designed as a first psychological treatment to
be combined with pharmacological treatment after established ADHD diagnosis
at adult age. She has also studied structured skills training groups for
adults with ADHD in an outpatient psychiatric clinic and in the context of
compulsory care due to severe substance use disorder. Further research topics
of interest are stress and long-term outcome in adults with ADHD.
During recent years Tatja Hirvikoski has broaden her research interest to
include autism spectrum conditions (ASC) and currently study long-term
outcome as well as interventions for people with ASC and their significant
others.